SEC Comment Letter 0000000000-23-009051 to ROCKWELL MEDICAL, INC. (RMTI) (CIK 0001041024) (RMTI)
ROCKWELL MEDICAL, INC. (RMTI) (CIK 0001041024)
Date: Aug. 18, 2023 · CIK: 0001041024 · Accession: 0000000000-23-009051
AI Filing Summary & Sentiment
File numbers found in text: 333-273983
Letter
United States securities and exchange commission logo August 18, 2023 Mark Strobeck Chief Executive Officer Rockwell Medical, Inc. 30142 S. Wixom Road Wixom, Michigan 48393 Re:Rockwell Medical, Inc. Registration Statement on Form S-3 Filed August 15, 2023 File No. 333-273983 Dear Mark Strobeck: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jimmy McNamara at 202-551-7349 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Ryan Murr
Show Raw Text
United States securities and exchange commission logo
August 18, 2023
Mark Strobeck
Chief Executive Officer
Rockwell Medical, Inc.
30142 S. Wixom Road
Wixom, Michigan 48393
Re:Rockwell Medical, Inc.
Registration Statement on Form S-3
Filed August 15, 2023
File No. 333-273983
Dear Mark Strobeck:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jimmy McNamara at 202-551-7349 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Ryan Murr